Giuseppe Danilo Norata
Giuseppe Danilo Norata
Professor of Pharmacology, University of Milan
Verified email at unimi.it - Homepage
Title
Cited by
Cited by
Year
Identification of seven loci affecting mean telomere length and their association with disease
V Codd, CP Nelson, E Albrecht, M Mangino, J Deelen, JL Buxton, ...
Nature genetics 45 (4), 422-427, 2013
6872013
Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge
R Saxena, MF Hivert, C Langenberg, T Tanaka, JS Pankow, ...
Nature genetics 42 (2), 142-148, 2010
6422010
LOX-1, OxLDL, and atherosclerosis
A Pirillo, GD Norata, AL Catapano
Mediators of inflammation 2013, 2013
4272013
Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis
GD Norata, P Marchesi, VK Pulakazhi Venu, F Pasqualini, A Anselmo, ...
Circulation 120 (8), 699, 2009
2892009
Plasma resistin levels correlate with determinants of the metabolic syndrome
GD Norata, M Ongari, K Garlaschelli, S Raselli, L Grigore, AL Catapano
European journal of endocrinology 156 (2), 279-284, 2007
2742007
Leptin: adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery
GD Norata, S Raselli, L Grigore, K Garlaschelli, E Dozio, P Magni, ...
Stroke 38 (10), 2844-2846, 2007
2192007
The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases
GD Norata, C Garlanda, AL Catapano
Trends in cardiovascular medicine 20 (2), 35-40, 2010
1752010
Dihydrotestosterone decreases tumor necrosis factor-α and lipopolysaccharide-induced inflammatory response in human endothelial cells
GD Norata, G Tibolla, PM Seccomandi, A Poletti, AL Catapano
The Journal of Clinical Endocrinology & Metabolism 91 (2), 546-554, 2006
1732006
Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells
GD Norata, P Marchesi, A Pirillo, P Uboldi, G Chiesa, V Maina, ...
Arteriosclerosis, Thrombosis, and Vascular Biology 28 (5), 925-931, 2008
1602008
Emerging role of high density lipoproteins as a player in the immune system
GD Norata, A Pirillo, E Ammirati, AL Catapano
Atherosclerosis 220 (1), 11-21, 2012
1552012
Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice
GD Norata, P Marchesi, S Passamonti, A Pirillo, F Violi, AL Catapano
Atherosclerosis 191 (2), 265-271, 2007
1552007
Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosis
E Ammirati, F Moroni, GD Norata, M Magnoni, PG Camici
Mediators of inflammation 2015, 2015
1442015
Proprotein convertase subtilisin/kexin type 9 (PCSK9): From structure–function relation to therapeutic inhibition
G Tibolla, GD Norata, R Artali, F Meneghetti, AL Catapano
Nutrition, Metabolism and Cardiovascular Diseases 21 (11), 835-843, 2011
1412011
Effector memory T cells are associated with atherosclerosis in humans and animal models
E Ammirati, D Cianflone, V Vecchio, M Banfi, AC Vermi, M De Metrio, ...
Journal of the American Heart Association 1 (1), e000125, 2012
1402012
Circulating CD4+CD25hiCD127lo Regulatory T-Cell Levels Do Not Reflect the Extent or Severity of Carotid and Coronary Atherosclerosis
E Ammirati, D Cianflone, M Banfi, V Vecchio, A Palini, M De Metrio, ...
Arteriosclerosis, thrombosis, and vascular biology 30 (9), 1832-1841, 2010
1402010
HDL in innate and adaptive immunity
AL Catapano, A Pirillo, F Bonacina, GD Norata
Cardiovascular research 103 (3), 372-383, 2014
1352014
Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: molecular mechanisms and gene expression studies
GD Norata, L Grigore, S Raselli, L Redaelli, A Hamsten, F Maggi, ...
Atherosclerosis 193 (2), 321-327, 2007
1302007
The cellular and molecular basis of translational immunometabolism
GD Norata, G Caligiuri, T Chavakis, G Matarese, MG Netea, A Nicoletti, ...
Immunity 43 (3), 421-434, 2015
1262015
New therapeutic principles in dyslipidaemia: focus on LDL and Lp (a) lowering drugs
GD Norata, CM Ballantyne, AL Catapano
European heart journal 34 (24), 1783-1789, 2013
1202013
Targeting PCSK9 for hypercholesterolemia
GD Norata, G Tibolla, AL Catapano
Annual review of pharmacology and toxicology 54, 273-293, 2014
1152014
The system can't perform the operation now. Try again later.
Articles 1–20